Quantification of characteristic bone marrow biopsy features includes basic parameters such
as cellularity and fiber content. These are important to assess the dynamics of disease …

Histopathology of bone marrow (BM) biopsies plays a crucial role in the interdisciplinary
approach to diagnosis and classification of chronic myeloproliferative disorders (CMPDs) …

Following the introduction of the WHO classification of chronic myeloproliferative disorders
(MPDs), after approximately 5 years, a critical reappraisal appears to be warranted …

In myeloid malignancies, the neoplastic clone outgrows normal hematopoietic cells toward
BM failure. This event is also sustained by detrimental stromal changes, such as BM fibrosis …

PURPOSE: Multivariate risk classifications for chronic (stable)-phase Ph1+ chronic
myelogenous leukemia (CML) are generally focused on hematologic variables, and the …

In chronic myeloproliferative disorders, presenting or evolving myelofibrosis (MF) is
associated with significant morbidity and mortality. A systematically conducted evaluation of …

Dose‐escalated chemotherapy has proven utility in a variety of treatment settings, including
preparative regimens before bone marrow or hematopoietic stem cell transplantation …

The management of patients with chronic myeloid leukemia (CML) has been revolutionized
by the introduction of tyrosine kinase inhibitors (TKIs), which induce deep molecular …

In many haematological conditions the only curative option is stem cell (SCT) or bone
marrow (BM) transplantation. Little information exists about BM morphology following non …

The transplantation of bone marrow cells or isolated hematopoietic stem cells from the bone
marrow or peripheral blood is a widely utilized form of therapy for patients with incurable …